Myocardial Microvascular Dysfunction in Rheumatoid Arthritis
Publication/Presentation Date
12-1-2019
Abstract
BACKGROUND: The goal of this study was to assess the prevalence of myocardial microvascular dysfunction in rheumatoid arthritis (RA) patients without clinical cardiovascular disease and its association with RA characteristics and measures of cardiac structure and function.
METHODS: Participants with RA underwent rest and vasodilator stress N-13 ammonia positron emission tomography and echocardiography. Global myocardial blood flow was quantified at rest and during peak hyperemia. Myocardial flow reserve (MFR) was calculated as peak stress myocardial blood flow/rest myocardial blood flow. A small number of asymptomatic and symptomatic non-RA controls were also evaluated.
RESULTS: In RA patients, mean±SD MFR was 2.9±0.8, with 29% having reduced MFR (
CONCLUSIONS: Reduced MFR was observed in a third of RA patients without clinical cardiovascular disease and was associated with a measure of inflammation and with higher left ventricle mass and volumes. MFR in RA patients was similar to controls referred for clinical scans (symptomatic controls). Whether reduced MFR contributes to the increased risk for heart failure in RA remains unknown.
Volume
12
Issue
1
First Page
007495
Last Page
007495
ISSN
1942-0080
Published In/Presented At
Amigues, Isabelle et al. “Myocardial Microvascular Dysfunction in Rheumatoid ArthritisQuantitation by 13N-Ammonia Positron Emission Tomography/Computed Tomography.” Circulation. Cardiovascular imaging vol. 12,1 (2019): e007495. doi:10.1161/CIRCIMAGING.117.007495
Disciplines
Medicine and Health Sciences
PubMedID
30636512
Department(s)
Department of Medicine
Document Type
Article